Remarkably, ctDNA levels are not solely dictated by tumor volume but are also influenced by genetic factors, including mutations in genes such as EGFR or KRAS in non-small-cell lung cancer [102]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.